Kenvue's stock has underperformed since its IPO, with disappointing guidance cuts for 2023 and 2024, and minimal growth projected for 2025. Despite recent struggles, Kenvue's strong brand ...

SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today issued the following statement in response to ...

Kenvue Inc. (NYSE:KVUE) confirmed that it received activist Starboard Value's submission of four nominees for the consumer health company's board for the 2025 annual meeting. The Starboard ...